KCCQ | Scores (mean ± SD) | P valuea | |||
---|---|---|---|---|---|
NYHA I (n = 12) | NYHA II (n = 108) | NYHA III (n = 18) | NYHA IV (n = 3) | ||
Domains | |||||
Physical limitationsb | 90.6 ± 9.3 | 73.2 ± 25.1 | 51.4 ± 24.7 | 64.6 ± 2.9 | < 0.001 |
Symptom frequency | 91.3 ± 10.3 | 66.6 ± 29.9 | 54.2 ± 27.1 | 43.8 ± 32.3 | < 0.001 |
Symptom severity | 95.1 ± 6.6 | 78.0 ± 21.2 | 69.9 ± 24.6 | 63.9 ± 9.6 | < 0.001 |
Symptom stability | 64.6 ± 22.5 | 64.4 ± 30.0 | 54.2 ± 33.5 | 75.0 ± 25.0 | 0.592 |
Self-efficacy | 77.1 ± 21.9 | 69.3 ± 25.4 | 75.7 ± 19.9 | 50.0 ± 45.1 | 0.692 |
Social limitationsc | 59.7 ± 40.8 | 61.4 ± 34.6 | 44.8 ± 31.1 | 54.2 ± 41.2 | 0.151 |
Quality of life | 73.6 ± 16.2 | 55.8 ± 24.4 | 44.4 ± 21.6 | 55.6 ± 24.1 | 0.003 |
Summary scores | |||||
Total symptom score | 93.2 ± 7.2 | 72.3 ± 24.8 | 62.0 ± 24.1 | 53.8 ± 20.4 | < 0.001 |
Clinical summary score | 91.9 ± 6.8 | 72.2 ± 22.8 | 57.4 ± 21.3 | 54.2 ± 18.4 | < 0.001 |
Overall summary score | 80.0 ± 12.5 | 65.4 ± 23.2 | 51.4 ± 20.5 | 53.5 ± 20.8 | < 0.001 |